The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Self-citationDahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Julius, S., Kjeldsen, S. E., Weber, M., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,558
Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 2,014
Hansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & de Faire, U. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,447
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406
Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes
Saydah, S. H. (2004) · JAMA · doi:10.1001/jama.291.3.335 · Cited by 1,357
Khaw, K.-T. (2001) · BMJ · doi:10.1136/bmj.322.7277.15 · Cited by 1,017
Khaw, K.-T., Wareham, N., Bingham, S., Luben, R., Welch, A., & Day, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00006 · Cited by 974
Pollare, T., Lithell, H., & Berne, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211305 · Cited by 856
Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025028 · Cited by 752
A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study
Haffner, S. M., Gonzalez, C., Miettinen, H., Kennedy, E., & Stern, M. P. (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1138 · Cited by 553
Treatment of Hypertension in Adults With Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s80 · Cited by 497
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
The Treatment of Hypertension in Adult Patients With Diabetes
Arauz-Pacheco, C., Parrott, M. A., & Raskin, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.134 · Cited by 326
Giugliano, D., Acampora, R., Marfella, R., De Rosa, N., Ziccardi, P., Ragone, R., De Angelis, L., & D'Onofrio, F. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00004 · Cited by 302
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Garg, J. P., & Bakris, G. L. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm412ra · Cited by 278
Self-citationYuyun, M. F. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh008 · Cited by 192
Colagiuri, S., Cull, C. A., Holman, R. R., & For the UKPDS Group (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1410 · Cited by 183
Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension
Pedrinelli, R., Dell’Omo, G., Bello, V. D., Pontremoli, R., & Mariani, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001316 · Cited by 135
Manley, S. E. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.182 · Cited by 116
Dornhorst, A., Powell, S., & Pensky, J. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91900-2 · Cited by 100
C-Reactive Protein Modifies the Relationship Between Blood Pressure and Microalbuminuria
Stuveling, E. M., Bakker, S. J. L., Hillege, H. L., Burgerhof, J. G. M., de Jong, P. E., Gans, R. O. B., & de Zeeuw, D. (2004) · Hypertension · doi:10.1161/01.hyp.0000120125.08867.42 · Cited by 99
Hak, E., Wei, F., Nordin, J. D., Mullooly, J. P., Poblete, S., & Nichol, K. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/381165 · Cited by 89
Song, S. H., & Brown, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01116.x · Cited by 72
Giordano, M., Matsuda, M., Sanders, L. R., et al. (1995) · Diabetes · doi:10.2337/diab.44.6.665 · Cited by 72
Holzgreve, H. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00062-1 · Cited by 68
Packer, M. (2003) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2003.08.003 · Cited by 67
Yasunari, K., Maeda, K., Nakamura, M., Watanabe, T., Yoshikawa, J., & Asada, A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.029 · Cited by 66
HAWKINS, C. M., Richardson, D. W., & Vokonas, P. (1983) · PubMed · Cited by 66
Giugliano, D., Marfella, R., R, A., Giunta, R. E., Coppola, L., & D’Onofrio, F. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.631 · Cited by 65
Galletti, F., Strazzullo, P., Capaldo, B., Carretta, R., Fabris, F. M., Ferrara, L. A., Glorioso, N., Semplicini, A., & Mancini, M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917030-00018 · Cited by 39
Influence of Carvedilol on Blood Glucose and Glycohaemoglobin A1 in Non-Insulin-Dependent Diabetics
Ehmer, B., van der Does, R., & Rudorf, J. (1988) · Drugs · doi:10.2165/00003495-198800366-00023 · Cited by 25
Carvedilol Inhibits Pressure-Induced Increase in Oxidative Stress in Coronary Smooth Muscle Cells.
Yasunari, K., Maeda, K., Nakamura, M., et al. (2002) · Hypertension Research · doi:10.1291/hypres.25.419 · Cited by 17
Östman, Asplund, Bystedt, Dahlöf, Jern, Kjellström, Lithell, & FOR THE SWEDISH QUINAPRIL GROUP (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00319.x · Cited by 17
Antihypertensive drugs and the hypertensive diabetic patient.
Feher, M. D. (1990) · PubMed · Cited by 2
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Blood Pressure · doi:10.3109/08037050903450468 · Cited by 894
Grundy, S. M. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.10.004 · Cited by 882
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2014) · Blood Pressure · doi:10.3109/08037051.2014.868629 · Cited by 739
Metadata
- Authors
- Bakris, G. L., Fonseca, V., & Katholi, R. L.
- Venue
- ACC Current Journal Review
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 14
- Issue
- 2
- Pages
- 20
- ISSN
- 1062-1458 (ISSN-L)
- OpenAlex
- W2097110468
- Cited by
- 256
- References
- 40
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.